Monday, July 11, 2022



Natural Immunity 97 Percent Effective Against Severe COVID-19 After 14 Months: Study

The protection against severe illness from so-called natural immunity remains superior to the protection bestowed by COVID-19 vaccines, according to a new study.

People who survived COVID-19 infection and were not vaccinated had sky-high protection against severe or fatal COVID-19, researchers in Qatar found.

“Effectiveness of primary infection against severe, critical, or fatal COVID-19 reinfection was 97.3 percent … irrespective of the variant of primary infection or reinfection, and with no evidence for waning. Similar results were found in sub-group analyses for those ≥50 years of age,” Dr. Laith Abu-Raddad, with Weill Cornell Medicine-Qatar, and colleagues said after studying long-term natural immunity in unvaccinated people.

That percentage is higher than the protection from COVID-19 vaccines, according to other studies and real-world data.

Swedish researchers, for instance, found in May that two doses of a vaccine were just 54 percent effective against the Omicron variant of the virus

South African scientists, meanwhile, found the effectiveness of the AstraZeneca and Pfizer vaccines peaked at 88 percent, and quickly dropped to 70 percent or lower.

The Qatar group found natural immunity for over 14 months after a person’s first infection “remains very strong, with no evidence for waning, irrespective of variant.”

The study was published ahead of peer review on the website medRxiv.

Few researchers have studied natural immunity long-term among unvaccinated persons, in part because many of the people have eventually received a COVID-19 vaccine.

The vaccines, meanwhile, have waned against both infection and severe illness over time, triggering recommendations for booster doses, with some Americans even getting five doses within 10 months.

The vaccines were once said to provide close to 100 percent protection against symptomatic infection. They now provide under 50 percent protection against infection after a short period of time, even after booster doses, following the emergence of Omicron.

That strain and its subvariants are dominant in countries around the world, including the United States and Qatar.

Natural immunity was thought to provide strong protection against reinfection. But the Qatari researchers found it also provides poor protection against reinfection from Omicron.

Poor protection against Omicron

Pre-Omicron infection against pre-Omicron reinfection was as high as 90.5 percent, and remained around 70 percent by the 16th month, according to the study. But pre-Omicron infection against Omicron reinfection was just 38 percent effective, although it was higher among people infected with the original Wuhan strain or with the Delta variant, and lower among those who got sick from the Alpha or Beta strains.

Modeling signaled a drop to zero percent protection by 18 months, but the shielding still appears to last longer than that of vaccines, researchers said.

“Vaccine immunity against Omicron subvariants lasts for <6 months but pre-Omicron natural immunity, assuming Gompertz decay, may last for just over a year,” they wrote.

Limitations of the study included differences in testing frequency among the cohorts studied, and depletion of groups who had a COVID-19 infection due to deaths.

************************************************************

Biden and Fauci Botched the Covid Pandemic Response

There are many lessons to be gleaned from the U.S. pandemic response. House Democrats don’t care to study them.

The House Select Subcommittee on the Coronavirus Crisis last month issued a deeply partisan report demonizing doctors who purportedly espoused “a dangerous and discredited herd immunity via mass infection strategy.” The report took aim at the Trump administration’s embrace of the October 2020 Great Barrington Declaration, in which epidemiologists Martin Kulldorff (Harvard), Sunetra Gupta (Oxford) and Jay Bhattacharya (Stanford) advocated protecting the elderly and vulnerable while allowing schools and businesses to reopen. This wasn’t a strategy to infect masses of people on purpose. The goal was to minimize deaths and social and economic harm until the country reached herd immunity through infection or vaccination.

The Great Barrington strategy of “focused protection” helped minimize the pandemic’s collateral damage until vaccines became available. The Biden administration then undertook a strategy of herd immunity via vaccination. But when this strategy failed, it doubled down with vaccine mandates.

From the outset of the pandemic, the mainstream medical establishment and government bureaucracy were aligned behind a lockdown-at-all-costs strategy. The Trump White House tapped Scott Atlas, a Hoover Institution fellow and radiologist, for a contrarian perspective. Dr. Atlas endorsed the elements of the Great Barrington strategy. The House report criticizes him for a memo in which he argued that “stopping all cases is not necessary, nor is it possible. It instills irrational fear into the public. Non-prioritized testing is jeopardizing critical resources for truly critical testing and is creating problematic delays in test results for the most important populations.”

He was right on every point. Indiscriminate use of a scarce resource reduces public welfare. When tests were in short supply, Dr. Atlas’s recommendation to save them for high-risk groups such as nursing-home residents made eminent sense. His prescriptions and those of the Great Barrington Declaration aimed to maximize public welfare.

Democrats claim in their report that 130,000 lives could have been saved with more “mitigation,” but this is doubtful. California and New York, which adopted mask mandates and lockdowns during the 2020-21 winter, fared no better than Florida and Texas, which didn’t. What’s more, employment continues to lag significantly in liberal lockdown states. Had all 50 states stayed shut down until vaccines were available, with the federal government paying tens of millions of people not to work—as Democrats ostensibly would have done—we might now be experiencing high unemployment and even higher inflation.

Vaccines ultimately saved the day by reducing the Covid disease burden and giving Democratic states a reason to lift their destructive lockdowns. But the Biden administration bet too heavily on vaccines to confer herd immunity. In December 2020, Anthony Fauci projected that a 75% to 85% vaccination rate could provide a “blanket of herd immunity.” This proved too optimistic.

An ever-mutating and increasingly transmissible virus, combined with waning vaccine effectiveness, made herd immunity a moving target. By spring 2021, Pfizer’s clinical trial data showed that its vaccine was becoming less protective against infection as time passed. Four months after the second dose, vaccine efficacy had declined to 84%, making breakthrough infections more likely and imperiling the Biden administration’s goals. Yet Pfizer honcho Albert Bourla writes in his new book, “Moonshot,” that federal public-health officials feared disclosing this waning efficacy would breed more vaccine hesitancy. The Biden administration kept it under wraps until July, when breakthrough infections in Provincetown, Mass., made it impossible to deny. Stories in the media were corroborated by a study from Israel the same month showing vaccine protection against infection falling to 39%.

Only after the Washington Post published a leaked Centers for Disease Control and Prevention slide presentation showing that vaccine efficacy was declining did the agency acknowledge it. Still, Dr. Fauci in August insisted that herd immunity could be achieved “really easily if we get everyone vaccinated.” He should have known by then that was false.

None of these realities stopped the Biden administration from mandating vaccines for private workers and arguing in court, despite evidence to the contrary, that doing so was “necessary to protect unvaccinated workers from the risk of contracting COVID-19” and “that vaccines dramatically reduce the risk of contracting and transmitting COVID-19.” After the Supreme Court blocked the mandate in January, the administration pivoted to a strategy of focused protection—e.g., distributing antiviral and monoclonal-antibody treatments and booster shots to the vulnerable. Alas, the administration’s orders were too little, too late to help when deaths and hospitalizations soared in winter 2021-22.

Nearly 600,000 Covid deaths have occurred on Mr. Biden’s watch despite vaccines and better treatments—about 180,000 more than under Donald Trump. One lesson is the importance of diverse opinions. The Biden administration paid too much heed to experts such as Dr. Fauci and ignored those who argued against placing all its eggs in the vaccine basket.

Another lesson is that science evolves, and there’s no shame in admitting error. Most scientists were wrong about what it would take to achieve herd immunity. But it’s better to correct mistakes than compound them, which is what the Biden administration did. Why it did is something for a future GOP Congress to investigate.

**********************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

**************************************************

Sunday, July 10, 2022



New omicron variant BA. 2.75 erupts out of India

Evolution can’t be held back. Especially when it comes to the Covid-19 virus. Yet another variant has appeared. This time in India. And it appears adapted to evade our immune response.

It passes through 1000 generations each month. That’s more than enough genetic dice rolls for successful mutations to establish their dominance.

The latest coronavirus variant identified as a potential cause for concern is variant BA 2.75 – nicknamed “Centaurus”.

It was first identified in India, but has already been detected in Japan, Germany, the United Kingdom, the United States, New Zealand – and Australia.

“There’s minimal data about this variant so far,” says Austrian Academy of Sciences geneticist Dr Ulrich Elling. “But it has a couple of attributes that have made us take notice.”

The Centaurus variant is a mutation of a mutation, developed from the older Omicron BA. 2 variant.

It’s the BA. 5 variant that is currently causing so much concern as it takes hold in Australia. What makes it more successful is the great ease with which it infects new hosts.

But BA. 2.75, which is only in the early stages of study, appears able to dodge any immunity built up against its parent BA.2.

Put simply, that means anyone who had Covid BA. 2 will be just as susceptible to catching it again as they were the first time around. And its even greater difference to BA. 5 could also result in a lack of immune system “recognition”.

European researchers have found BA. 2.75 to have eight extra spike protein mutations. These are the nodules found on the surface of a virus that act as “keys” to unlock a host’s cells.

The locations of these “keys” give scientists clues about their capabilities.

In the case of BA. 2.75, they’re clustered in a way that could conceal its identity to an immune system familiar with its parent. And that makes it even more distinct from the current dominant coronavirus strain – BA.5.

They’re in what’s called the N-terminal domain (NTD) – one of the more prominent protuberances of the virus.

“The NTD is decorated with mutations in BA. 2.75 in and around the neutralising antibody binding “supersite” and could thus enhance immune evasion in that region,” Dr Elling explains.

And circumstantial evidence supports this: BA. 2.75 has already been able to establish footholds around the world with extraordinary speed.

Dr Elling says the number of mutations in BA. 2.75 is “remarkable”. Omicron Delta had a similar number, but just three mutations were enough to supercharge BA.5.

“Thus, the 11 mutations distinct between BA. 5 and BA. 2.75 could allow for yet another wave as BA. 5 immunity might not protect,” Dr Elling warns. “I really hope this highly speculative thread will turn out to be a false alarm!”

“Before we are done with the BA. 5 wave, we might already have to prepare for the next,” Dr Elling tweeted. “Confirmed cases are very few still today. But the international distribution excludes sequencing errors and makes it highly likely that the real numbers are way higher.”

And the warning signs are in place.

“It is really too early to know if BA. 2.75 will take over relative to BA. 2 or even relative to BA. 5,” he adds, “but it is remarkable to note that BA. 2.75 carries alternative “solutions” in the regions mutated in BA.5.”

Viruses evolve fastest in chronic infections. It’s where one host’s immune system spends the greatest time fighting back. And the weakened nature of that fightback exposes multiple generations of the virus to a greater variety of “counter-attacks”. Those mutations that dodge these counter-attacks then go on to breed.

Imperial College London virologist Tom Peacock said he believed such cases were likely to be the cause of such significant changes seen in the likes of BA. 2.75.

“None of these individually really flag as that worrying but all appearing together at once is another matter,” he tweeted.

“It looks like something is headed toward us,” says Dr Elling. “But there’s no sure-fire evidence just yet.”

**********************************************

COVID Vaccines Increase Menstrual Irregularities

New disturbing pharmacovigilance signals from VAERS surrounding the use of the COVID vaccines on women of reproductive age prompted a group of doctors to call for a ban on the gene therapy COVID-19 vaccines.

Over the past two weeks, Dr. James Thorp, a maternal-fetal medicine expert, painstakingly analyzed and verified the most recent Vaccine Adverse Event Reporting System (VAERS) data related to COVID-19 vaccines and compared them to the influenza vaccines.

“COVID-19 vaccines compared to the influenza vaccines are associated with increases in menstrual disorders, miscarriage, fetal chromosomal abnormalities, fetal cystic hygroma, fetal malformations, fetal cardiac arrest, fetal cardiac arrhythmias, fetal cardiac disorders, fetal vascular mal-perfusion abnormalities, abnormal fetal surveillance testing, abnormal fetal growth patterns, placental thrombosis, and fetal death,” Thorp told The Epoch Times last week.

His findings are listed below:

Abnormal uterine bleeding (menstrual irregularity) is 1000-fold greater
Miscarriages are 50-fold greater
Fetal chromosomal abnormalities are 100-fold greater
Fetal malformation is 50-fold greater
Fetal cystic hygroma (a major malformation) is 90-fold greater
Fetal cardiac disorders are 40-fold greater
Fetal arrhythmia is 50-fold greater
Fetal cardiac arrest is 200-fold greater
Fetal vascular mal-perfusion is a 100-fold greater
Fetal growth abnormalities are 40-fold greater
Fetal abnormal surveillance tests are 20-fold greater
Fetal placental thrombosis is 70-fold greater

Thorp said that he verified his analysis with a DOD (Department of Defense) statistical consultant that agreed to help him on the condition of anonymity.

Lack of Safety Testing

Regarding the VAERS data, vaccinologist Dr. Robert Malone, a key contributor of mRNA technology, told The Epoch Times on Thursday: “The risky strategy of authorizing the emergency use of mRNA ‘vaccine’ products prior to completion of rigorous non-clinical animal testing for reproductive and genotoxicity risks, followed by advocacy of widespread use in pregnancy, now appears to have resulted in substantial and avoidable reproductive toxicity.”

“Prior non-clinical (animal model) data from the Pfizer Emergency Use Authorization data package, together with the absence of adequate data and testing of safety during pregnancy have resulted in avoidable reproductive and fetal toxicities,” Malone further noted.

He stressed that expectant mothers should avoid the “experimental” COVID vaccines and that their infants should not be injected with them.

“These new VAERS data and analyses demonstrate that both reproductive-aged mothers and their infants have been damaged by accepting unlicensed, inadequately tested, emergency use authorized genetic vaccines,” Malone said.

Earlier this year Jessica Rose Ph.D. co-authored a VAERS analysis that got withdrawn by the academic journal Elsevier.

She told The Epoch Times that Thorp’s analysis aligns perfectly with hers.

“I do believe it is not only important, but necessary, to pull these products from pregnant/breastfeeding women and infants since there is no long-term safety data and the short-term data looks bad. As per both Moderna and Pfizer’s safety documents presented to VRBPAC pre-EUA granting for 0- 4-year-olds, this applies. They both showed terrible risk,” Rose said.

Christiane Northrup, MD., a fellow of the American College of Obstetrics and Gynecology, also stands by the analysis.

“Having been on the front lines of the DES disaster as a young OB/GYN, I am astounded that we are repeating the same kind of mistake but on a far more devastating level. COVID-19 shots must be stopped immediately in all pregnant women before further damage is done to the next generation,” Northrup told The Epoch Times.

Thorp continued: “All of these adverse outcomes are statistically significant (p value < 0.0001)–in other words, the probability of these adverse outcomes occurring by chance alone is less than 1 in 10,000. It was incumbent upon the COVID-19 vaccine manufacturers, FDA, CDC, American College of Obstetrics and Gynecology, Society for Maternal-Fetal Medicine, and American Board of Obstetrics and Gynecology to have demanded this safety data prior to pushing these dangerous ‘vaccines’ in pregnancy.”

“These institutions have violated the golden rule of pregnancy: new substances be it nutraceuticals, drugs, or vaccines have NEVER been allowed in pregnancy until long-term outcome data are available. Now, the COVID-19 vaccines make prior obstetrical disasters of diethyl stilbesterol (DES) and thalidomide look like prenatal vitamins. I am calling for a worldwide ban and moratorium on the use of any experimental gene therapy and/or COVID-19 ‘vaccines’ in pregnancy until long-term safety data are irrefutable,” Thorp stated.

**********************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

**************************************************

Friday, July 08, 2022



Corrupt science in a leading medical journal

"Lancet" has been Left-run for some time. They even campaigned against George Bush and the Iraq war. See here

There is supposed to be a clear line between medical publishing and propaganda. No less so than in the pages of the Lancet, previously considered a relative bastion of integrity in publishing. Honesty in medical publishing, meaning publication on the basis of transparent rigorous review and impartiality, is of particular importance to medicine and public health. The outcomes of such publications contribute to saving or killing people.

In 2020 the Lancet published an apparently fraudulent study discrediting the use of hydroxychloroquine in the management of COVID-19. While this was later withdrawn, it should not have passed first glance of a serious editor, as the data published by a previously unknown institution could not be credibly collated in the timeframe concerned.

A Lancet ‘commission’ to investigate the origins of SARS-CoV-2 included people who had direct conflict of interest, as they would potentially be culpable if its findings revealed a lab-based origin. This followed the publication of a letter stating that a lab-release origin of SARS-CoV-2 was a ‘conspiracy theory’ and ‘misinformation,’ despite the first cases being reported within a few miles of the Wuhan Institute of Virology where research on SARS-like viruses was being performed, hundreds of miles from the habitat of the putative zoonotic hosts.

The Lancet again apparently missed the obvious conflict of interest in this letter’s authorship until forced to confront it.

Together with the Lancet’s unquestioning acceptance of mass vaccination in countries with very low mortality and high competing priorities, and its pushing of ‘zero-Covid’ in the context of a global spread with no transmission-blocking interventions, the journal’s poor history on COVID-19 does suggest an intentional bias.

Modeling Fantasy for Profit

Last week, the Lancet published a modeling study by Oliver Watson and others from Imperial College London, funded by, among others, the Bill & Melinda Gates Foundation. This predictive model from Imperial College suggests that COVID-19 vaccination introduced at the end of 2020 saved 14.4 to 19.8 million lives in the subsequent 12 months. A summary is provided here. The Imperial College modeling team previously massively overstated anticipated COVID-19 deaths in 2020.

Models should pass basic credibility criteria to be published, based on plausibility. Alternatively, a lack of coherence with real-world data or known biology should be stated. For reasons upon which one can only speculate, the Lancet again seems not to have actually assessed the credibility of the paper prior to publication. This matters, as others who lack an apparent basic understanding of scientific process, such as The Economist and various commentators on social media, then disseminate the model’s predictions as fact.

People can die when public health is twisted in this way.

Vaccination against SARS-CoV-2 commenced in late 2020, and significant vaccination rates were not achieved in most populations until at least a few months into 2021. In a respiratory virus outbreak the most vulnerable, most likely to die, are likely to be overrepresented in mortality in year one. However, this first year did not produce anything like the mortality claimed to have been ‘saved’ by the vaccines in 2021. Lockdowns and other nonpharmaceutical interventions don’t account for this.

Post-infection immunity is effective in mitigating COVID-19, and more so than vaccination alone. Serological surveys indicate that most people gained post-infection immunity by mid- to late-2021. As infection rates are higher than vaccination rates for much of the world’s population, post-infection immunity would be expected to play a larger role than vaccination in reducing subsequent mortality. The African continent, with the lowest vaccination rate, has the lowest mortality rate—a multi-factorial relationship but one that should have given the Lancet, The Economist, and any thinking person pause for thought.

One could argue that vaccination was more targeted to the highly vulnerable and so disproportionately impactful—but this would run against the Lancet paper’s claim that higher vaccination rates would save even more people. The vaccine is not transmission-blocking, so the vulnerable minority account for nearly all possible vaccine impact.

The suggestion by Watson et al. that all-cause mortality can be used as a proxy for COVID-19 also runs foul of the evidence in two areas:

Firstly, randomized controlled trials of the mRNA COVID-19 vaccines show a small excess all-cause mortality in the vaccinated group over the placebo. This alone makes a substantial reduction in overall mortality through vaccination unlikely, with adverse events possibly promoting non-COVID-19 mortality.

Secondly, a large increase in all-cause mortality is associated with, and expected from, lockdown measures. This is evidenced by rising malaria and tuberculosis, reduced childhood vaccination, and over 75 million added people in extreme poverty. Poverty raises mortality, killing infants in particular. UNICEF estimated 228,000 child lockdown deaths in the 6 countries of South Asia in 2020 alone, and when extrapolated across sub-Saharan Africa and through 2021 this is a lot of dead children. So lockdown deaths, which are not from COVID-19, comprise a large part of excess mortality.

Modeling or reporting COVID-19 ‘mortality’ or ‘lives saved’ raises a further issue that the Lancet and the wider media have consistently overlooked. COVID-19 deaths are concentrated in the elderly (age >75 years) with multiple comorbidities. This is the population sub-group most likely to die in the next months or year.

A child saved from malaria is likely to gain 70 years of life, while a person saved from COVID-19 is likely to gain one year or less. While that year is important, relatively few would equate it to their grandchild’s potential loss. It also means the term ‘saved’ requires considerable nuance, as those that Watson et al. claim were ‘saved’ by the vaccines in the first half of 2021 are likely to have died by now from something else.

This is why metrics incorporating life-years lost or disabled were standard up to 2020, including in the Lancet’s lucrative partnership with IHME on the Global Burden of Disease assessments funded by the Bill & Melinda Gates Foundation. To abandon these metrics when a pandemic appears that overwhelmingly targets those with the shortest life expectancy is extraordinary.

Weighing Lives and Profit

Tens of billions of dollars are being generated for large pharmaceutical companies and their investors through mass vaccination for COVID-19. The Lancet is a business, and as such is dependent on pleasing these dominant influencers of medical research. As diversion of resources from diseases of higher burden to mass-vaccination of young immune populations in low-income countries is demonstrably harmful to overall health through resource diversion and general impoverishment, this presents difficulties for the Lancet.

Killing children en masse is a bad look for a medical journal, but the evidence indicates this resource diversion will do, and the Lancet clearly feels inclined to support it. When a major Lancet partner faces significant income loss if the mass-vaccination paradigm is questioned, standing on principle and ethics would have taken courage and incurred risk.

This is the ethical dilemma that the high level of private investment in public health has brought. Pharma investors sponsor ‘global health’ schools, research, modeling and the public health institutions, including the WHO, which use their outputs. For-profit publishing houses must be aligned with these funding sources to thrive.

The losers in all this are the populations who have commodity (i.e. vaccine) ‘equity’ forced on them at the expense of health equity and the freedom to choose. As malaria, malnutrition, and other diseases of poverty increase, public health and its medical journals must focus elsewhere on areas profitable to their funders.

Succumbing to conflicts of interest is hardly new in human society, and humans are excellent at justifying it. This is why we need external oversight in areas where such conflicts can cause great harm. New rules on conflict of interest and transparency are needed in medical publishing, including reforms to ensure transparent peer review and open access to rebuttals of published papers. For-profit institutions cannot be the main arbiter in determining what health information reaches the public.

For now, though, it is difficult to see a path to improvement unless the publishers themselves value integrity, and the journalists interpreting them value truth. We have allowed vested interests to dominate public health discourse because we value their money more than the printed word. This matters because honesty in medical publishing determines the quality of life, and likelihood of death, of people. It is not an abstract problem.

**********************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

**************************************************

Thursday, July 07, 2022

The CDC Is Breaking Trust in Childhood Vaccination


On June 18, the U.S. Centers for Disease Control and Prevention (CDC) officially recommended Pfizer and Moderna COVID-19 vaccines for all children between the ages of 6 months and 5 years. While the Food and Drug Administration (FDA) is the agency responsible for authorizing emergency use of vaccines, it’s the CDC that crafts subsequent messaging, makes specific recommendations, and prioritizes who can, should, or should not get vaccinated. In her briefing, CDC Director Rochelle Walensky strongly urged all parents of the nearly 20 million American children in this age group to vaccinate them as soon as possible.

For some parents, Walensky’s briefing came as a huge relief. But if polling from May is anything to go by, a larger number of parents likely greeted the recommendation with skepticism. Even before the underwhelming trial results came out, only 18% of surveyed parents reported that they planned to vaccinate their babies and toddlers. Nationally, uptake in minors between the ages of 5 and 11 as of June 22, 2022, was 29% receiving two doses, and 36% receiving one, but vaccine requirements for sports, camps, and other activities likely drove an unknown percentage of vaccination in this age group.

The Dissidents

There remains, moreover, no solid consensus among physicians about the importance of vaccinating healthy children against COVID-19. A survey from December 2021 indicates that as many as 30%-40% may not be recommending COVID vaccination for children ages 5 to 17, to say nothing of infants. A recent editorial in The Lancet expressed uncertainty about whether the benefits of vaccinating healthy 5- to 11-year-olds outweigh the risks, especially in those with a history of infection.

The gap between the CDC’s enthusiasm for vaccinating all children against COVID and that of parents and health care providers is unlikely to be bridged by approval under Emergency Use Authorization. Approval for the COVID vaccines in infants and toddlers is based on two trials that used changes in antibody levels as an estimate of efficacy, but did not assess protection from severe disease, hospitalization, or multisystem inflammatory syndrome in children (MIS-C), important outcomes that parents worry about. In a Food and Drug Administration (FDA) meeting on June 28, Pfizer Vice President for Viral Vaccines Kena Swanson even acknowledged that “there is no established correlate” between antibody levels and protection from disease.

In the Pfizer trial, the confidence interval—which shows the possible range of protection level—was alarmingly wide, with the lower bound suggesting the possibility of a 380% increase in the chance of infection after the third dose. Additionally, neither trial met the 50% efficacy requirement established by the FDA for approval of adult COVID vaccines. Peter Marks, the FDA’s top vaccine official, told Congress in May that the efficacy requirement would be lowered for the pediatric vaccine simply because vaccine efficacy against the omicron variant was lower in general.

With rates of severe disease now much lower in children than at the start of the pandemic—due to higher levels of natural immunity and lower rates of severe disease caused by omicron—trials would have needed to enroll hundreds of thousands of children, if not over a million, in order to detect a significant impact of the pediatric vaccine against severe disease. Vaccine companies could have conducted such time-consuming and costly trials, especially if there had been interest in international collaboration. But there was no economic incentive to do so, and every economic incentive not to: Speed, not providing meaningful information to parents and physicians about safety and efficacy, was the priority of U.S. regulatory agencies.

Because Pfizer and Moderna were permitted to seek approval for pediatric COVID vaccines under the emergency use pathway, Moderna only enrolled 6,300 total children in trials (4,700 in the vaccine group and 1,600 in the placebo group), and Pfizer only enrolled 4,526 total (2,750 in the vaccine group and 1,776 in the placebo), with two-thirds dropping out before the third dose. The trials, in other words, enrolled only a fraction of the number of participants that would have been required to determine efficacy against end points like severe disease, hospitalization, and rare adverse events such as myocarditis, which has been linked to COVID vaccination in males in the 12- to 17-year-old age group at a rate of up to 1 in 2,700.

Furthermore, the follow-up time after the second dose of Moderna and the third dose of Pfizer was only 1-3 months. Data from adults show protection against infection is transient, though protection against severe disease so far seems longer lasting. For the Moderna vaccine, efficacy against infection was not statistically significant for children between 6 months and 2 years, according to one of the company’s two analyses. In the Pfizer trial, there was no evidence of efficacy for the first two doses against omicron for this age group; the “effect” seen after the third dose was so uncertain that it is impossible to draw firm conclusions about how well the vaccine worked to prevent cases.

Still more puzzling is the fact that neither Pfizer nor Moderna—despite continued assurances that mRNA vaccines are uniquely flexible, allowing manufacturers to quickly tweak vaccines to match new variants—has released an updated version of their product: The pediatric vaccines now being administered target an outdated variant. In addition, the infant and toddler trials were mostly limited to children who had not been previously infected with COVID (estimates based on blood work showed less than 15% of children enrolled had previously been infected). With 75% of children nationally having already been infected by February 2022, the immune-naive children enrolled in the trial were not representative of their age group at large.

The general trust deficit is more troubling than skepticism toward this particular vaccine.

Even in the already troubled context of the last two years, the CDC’s unqualified recommendation to vaccinate every young child against COVID may further contribute to the profound chasm of trust between U.S. citizens and their public health agencies. In January, a Hart poll found that only 44% of respondents said they believe what the CDC says; a March Gallup poll put it at 32%. Evidence of trust slippage can be seen even in highly vaccinated places like Portland, Oregon, where CDC recommendations were for the most part embraced unquestioningly during the pandemic. Despite the CDC’s recommendation that all children 5 and up should receive a booster, as of June 26 only 8.7% of children ages 5-11 in the Portland area are boosted, compared to 3.9% in the entire state of Oregon. (The CDC and American Academy of Pediatrics have not made nationwide data available.)

The general trust deficit is more troubling than skepticism toward this particular vaccine, because it could conceivably drive down uptake of other childhood vaccines that we know are more important to children’s health, such as those against measles, mumps, rubella, diphtheria, polio, and Haemophilus influenza type b (Hib). This is not an alarmist or trivial concern, as vaccinations are one of the most lifesaving medical interventions in human history, rivaled perhaps only by antibiotics. In 1800, 46% of American children did not make it to age 5, and the majority died from what are now vaccine-preventable diseases. The smallpox vaccine alone is estimated to have saved 150 million to 200 million lives. Rates of diseases such as tetanus, rubella, polio, Haemophilus influenza type b (Hib) have declined by 99% since widespread childhood vaccination became commonplace in the 20th century.

It is therefore worth our attention when, for example, a recent letter in the New England Journal of Medicine noted that flu shot uptake has decreased over the pandemic, which the authors suspect may be due to growing vaccine hesitancy in general. The CDC published a study in April showing that childhood vaccination rates fell by only 1% in 2021, a small proportion of the total when spread over 70 million children. But given that many of these vaccines require two or three doses for full coverage, this still translates to several million missing doses, and could threaten herd immunity for diseases such as measles, which require very high percentages of the population to be vaccinated. It is also difficult to separate out the factors behind this drop in coverage, because schools and local clinics—where many low-income children receive vaccines—were closed for much of the last two years. But it is reasonable to at least assume that low trust in the CDC, the agency responsible for making evidence-based recommendations about vaccines, is not helping.

Compare the CDC’s response to vaccine hesitancy during COVID to a similar challenge in the late 1990s and early 2000s: rotavirus. Only a year after Andrew Wakefield’s false claims in 1998 that the MMR vaccines caused autism—leading to one of the most disastrous setbacks for vaccination uptake in history—Wyeth’s RotaShield vaccine was pulled off the market due to evidence it caused a rare and serious intestinal malfunction (intussusception) in babies. The effect of the RotaShield withdrawal so hard on the heels of the Wakefield disaster is hard to isolate, but CDC officials acknowledged that the combined events led to “a particularly turbulent period” for U.S. vaccine programs. Referring to vaccine hesitancy that might result from the RotaShield adverse events, the CDC’s Dr. John Livengood remarked at the time that the CDC “shouldn’t be seen as withholding information right now.”

The original trial for RotaShield had enrolled 10,054 vaccine recipients and 4,633 placebo recipients. During a February 1998 meeting of the CDC’s Advisory Committee on Immunization Practices (the same body that recently met to discuss the pediatric COVID vaccines), an FDA panel member, Dr. Margaret Rennels, noted that more babies in the vaccine group experienced intestinal intussusception than in the placebo group by about 2.5-fold, with a rate of 1/2011 (0.05%) in the vaccine group compared with 1/4633 (0.02%) in the placebo. But because the absolute numbers were small, and the trial was also relatively small, intestinal intussusception did not achieve statistical significance. RotaShield was licensed by the FDA in 1998, widely rolled out, and championed by the CDC in the spring of 1999. Intussusception was not mentioned further, and the issue was buried in a 19-page document where it was listed as a side effect that did not occur significantly more often in vaccinated babies than in the control group.

By summer, however, officials at the CDC grew concerned about a growing number of intussusception reports from the Vaccine Adverse Event Reporting System (VAERS), and were anxious not to lose gains made during the Carter and Clinton administrations in raising general childhood vaccination rates. By the end of President Clinton’s first term, toddler immunization rates had achieved what was then an all-time high, thanks to Vaccines for Children, a program that expanded access to free and low-cost vaccination.

The CDC was also cognizant that Wakefield’s false claims were continuing to spur a growing movement of vaccine hesitancy. As a result, the CDC—then under the direction of Dr. Jeffrey Koplan—immediately launched a large-scale investigation into the RotaShield VAERS reports. The investigation concluded that one additional case of intussusception was attributable to the vaccine for every 5,000-10,000 infants vaccinated—lower than rates of myocarditis due to vaccine injury in COVID-vaccinated adolescent males age 12-17.

RotaShield was pulled off the market that October. To justify the decision to pull a vaccine that was 85% effective at preventing hospitalization from a viral infection that had killed hundreds of thousands of infants worldwide, CDC personnel wrote the following:

At a time when many parents express concerns about the safety of vaccines and vaccine adverse events are the focus of increasing attention by the public, media, and U.S. Congress, the wisdom of recommending a vaccine that causes a severe adverse reaction in an estimated 1 in 10,000 infants must be considered.

The next vaccine against rotavirus—RotaTeq, made by Merck and released in 2004—was only released after the Rotavirus Efficacy and Safety Trial (REST) trial, which was notable for its “[randomized] design, large sample size, detailed execution, continuous safety monitoring, and lengthy duration,” and was undertaken in direct response to the perceived failures of the RotaShield trial. The authors of a paper describing its execution wrote, “The design and conduct of this study may serve as a useful tool for planning other future clinical trials, especially those evaluating uncommon adverse events.” The REST trial was conducted in 11 countries at more than 500 study sites and enrolled 70,000 subjects (including over 35,000 infants from the United States), making it one of the largest vaccine clinical trials ever conducted pre-approval. Post-approval, Merck conducted an additional study enrolling more than 85,000 infants.

The obvious drawback of a trial like REST is that it took four years to complete (though today it could almost certainly be completed faster due to advances in recruitment methods). A multiyear trial was simply not an option during COVID, which is why the notably small and short COVID vaccine trials were allowed to serve as the basis for approval under the emergency use provision. But because COVID so rarely causes severe disease in children, and current COVID vaccines do not reliably prevent transmission, especially after a few months, it is difficult to understand how such small trials could be justified without meaningful endpoints for this age group.

https://www.tabletmag.com/sections/science/articles/cdc-is-endangering-childhood-vaccination-progress

**********************************************

Also see my other blogs. Main ones below:

<a href="https://edwatch.blogspot.com">http://edwatch.blogspot.com</a> (EDUCATION WATCH)

<a href="https://antigreen.blogspot.com">http://antigreen.blogspot.com</a> (GREENIE WATCH)

<a href="https://pcwatch.blogspot.com">http://pcwatch.blogspot.com</a> (POLITICAL CORRECTNESS WATCH)

<a href="https://australian-politics.blogspot.com/">http://australian-politics.blogspot.com/</a> (AUSTRALIAN POLITICS)

<a href="https://snorphty.blogspot.com/">http://snorphty.blogspot.com/</a> (TONGUE-TIED)

<a href="https://immigwatch.blogspot.com/">https://immigwatch.blogspot.com/</a> <b>(IMMIGRATION WATCH)</b>

<a href="https://awesternheart.blogspot.com/">https://awesternheart.blogspot.com/</a> (THE PSYCHOLOGIST)

**************************************************


Wednesday, July 06, 2022



Infection of wildlife biologist highlights risks of virus hunting

The illness was mysterious. A 25-year-old graduate student had been hospitalized with a high fever, muscle and joint pain, a stiff neck, fatigue, sores in her throat, and a metallic taste in her mouth. She soon developed an angry rash. To make the diagnosis, her doctors had an important data point to consider: Days earlier, the woman had returned to the United States from a field expedition in South Sudan and Uganda, where she had been capturing and collecting the blood and tissue of bats and rodents. That information proved critical — and is newly relevant given concerns that the pandemic may have come from a research accident. Three days after she was admitted to the hospital in 2012, tests determined that the student was infected with a novel virus that infects a type of fruit bat that lives in the rural areas of Uganda.

The graduate student recovered and left the hospital two weeks later. But the incident, which was written up in the journal Emerging Infectious Diseases in 2014, proved scientifically important. Not only did it allow for the identification of the Sosuga virus — a paramyxovirus named for Southern Sudan and Uganda — and the knowledge that the bat virus can infect and sicken people, the woman’s infection also pointed to the dangers posed by the kind of research she was doing: trapping, manipulating, and dissecting animals suspected of being infected with novel disease-causing viruses.

Biosafety experts have long worried over the possibility that scientists seeking dangerous viruses in the wild could inadvertently become infected in the course of either capturing or coming into contact with the saliva, urine, or feces of the animals. The case of the Sosuga virus shows that those concerns are well founded.

Virus hunter Michael Callahan, an infectious disease doctor who has worked for federal agencies on global disease outbreak and the tracking of wildlife pathogens, has vividly described the high risks faced by field researchers. “Squirming, clawed and toothy animals bite and scratch during collection of body fluids. Teeth and talons easily penetrate the thin gloves required to maintain dexterity when handling fragile wildlife,” he wrote in Politico in 2021. “The fact that researchers are not infected every time they do a field collection is a question that continues to stump us.”

With more than 6 million people now dead from Covid-19, the catastrophic potential of a researcher becoming infected with a wildlife pathogen has become inescapable. While the origins of the current pandemic are still unclear, it remains possible that virus hunting could have been the cause. Rocco Casagrande, a biochemist who was hired by the National Institutes of Health’s Office of Science Policy to assess the risks of gain-of-function research, thinks a natural spillover of the virus from animals to people, a lab accident, or what he calls a “prospecting based accident” are equally likely potential causes of the initial outbreak. He imagined the prospecting scenario as “the researchers in Wuhan looking for bat viruses found one and got infected outside of the lab.”

Even as the very real chance remains that the search for new viruses led to this cataclysmic event, scientists hoping to prevent viral outbreaks continue to seek out new bat coronaviruses and other potential pandemic pathogens around the world.

Ask the Bats

The search for pathogens that infect animals is driven by the desire to prevent and prepare for their possible transmission to people. But that work, which spans the globe and is funded in large part by the U.S. government, can sometimes result in human infection — exactly the outcome it is meant to prevent.

Virus hunting — or wildlife disease ecology, as DeeAnn Reeder prefers to call it — is a field that has come under increasing scrutiny during the Covid pandemic. For Reeder, a professor of biology at Bucknell College who led the 2012 expedition on which the graduate student was infected, one of the central purposes of her research in Africa on bats’ immune responses to viruses is to understand how humans might react to the same infectious agents, knowledge she says can protect us if the pathogens jump from animals to humans. “If you want to understand how to survive a coronavirus, or if you want to understand how to survive a filovirus — Ebola fits within that context — you need to ask the bats because they know how to do it,” said Reeder.

Reeder, who put up her first bat net in South Sudan in 2008, continues to do wildlife research in Uganda. No one has previously reported her connection to the work. “I’ve never been contacted by a reporter on that particular story,” Reeder said, after being asked whether the Sosuga virus infection occurred during research on one of her projects. “I’ve always been surprised about that.” Reeder would not confirm the identity of the researcher on her project who was sickened, citing privacy concerns.

The Sosuga case shows that concerns about viral transmission from wild animals to researchers are not just theoretical. It is still unclear exactly how the infection occurred. While the graduate student only occasionally used protective gear when working with animal specimens, when she visited the bat caves she wore a paper Tyvek suit that’s become the hallmark of virus hunters, gum boots, bite-resistant gloves, and even an air-powered respirator known as a PAPR that looks like an astronaut’s helmet. The researcher did not report being bitten or scratched by any of the animals she encountered.

“Maybe outside the cave before they put the respirators on, she leaned against a rock that had been peed on, because we know that it could be in the kidneys of this particular bat species,” said Reeder. “But that’s just conjecture, which is the scary part.”

****************************************************

Australians to get Omicron booster

Australia is set to be one of the first countries in the world to get access to an Omicron booster jab.

Moderna’s new Covid vaccine designed to fight the original Wuhan strain of the virus, as well as the Omicron variant, is currently being assessed by the Therapeutic Goods Administration (TGA).

“If approved, the company will be able to supply this new Omicron-containing bivalent booster vaccine within weeks- putting Australia among the first countries in the world to have access to this new COVID-19 vaccine,” Moderna’s managing director in Australia Michael Azrak told News Corp.

Health Minister Mark Butler told News Corp he wanted to be on “the front foot” in accessing the most up to date vaccines.

“I’ve had encouraging discussions with Moderna and Pfizer about the challenges of the new sub-variants and the positive developments in vaccine technology,” Mr Butler said.

“My department is in negotiations about future supply arrangements, including for under 5-year-olds and the variant vaccines,” he said.

Epidemiologists and other experts have been calling for more Australians to get a fourth jab as hospitals and health services buckle under massive pressure from both Covid and the flu.

The government’s expert advisory group on vaccines the Australian Technical Advisory Group on Immunisation (ATAGI) was meeting on Wednesday to decide whether more Australians should get access to a fourth Covid booster.

There are more than 16 million unused doses of the existing Covid vaccines siting in warehouses and doctors clinics.

Currently a fourth dose is only available to the elderly and those who are immunocompromised or suffering certain chronic conditions.

The existing Covid vaccines were designed to work against the original Wuhan variant.

A fourth dose of these vaccines has been shown in Israel to provide a 10-30 per cent increase in resistance to infection but this protection wanes within five to eight weeks.

However, this could be enough to get Australia through the worst of the winter outbreak.

But there is concern about whether the original jab provides much protection against the new BA. 4 and BA. 5 variants sweeping the nation.

These variants appear resistant to the existing vaccine and the antibodies produced by people who were infected with the original Omicron variant.

Mr Butler has appointed former Health Department chief Jane Halton to review Australia’s vaccine purchasing arrangements. She is expected to report within weeks.

Moderna said it “continues to have constructive discussions with the Australian Government regarding the supply of Moderna’s next generation Omicron containing bivalent vaccine booster for people 18 years and older”.

**********************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

**************************************************

Tuesday, July 05, 2022



Australia: Too late for mask mandates as Omicron continues to drive high case numbers

Omicron’s measles-like infectiousness, five times higher than any other Covid strain, is driving the continued high number of cases across the nation, but experts say Australia has done relatively well in terms of controlling case numbers.

They also say it is now too late for governments to impose restrictive rules and mask mandates, with the path out of Covid reliant instead on better public health messaging, better vaccines and earlier access to antivirals.

The reach of Omicron is clear in the numbers as the nation reached a grim milestone on Sunday, surpassing 10,000 Covid-­related deaths since the virus landed here in January 2020.

Of those deaths, almost 8000 were in the first half of this year when Omicron has been the dominant strain.

The majority of mortalities occurred in Victoria and NSW, with the states recording 3934 and 3590 deaths, respectively.

The 2022 death toll is nearly four times the previous two years’ mortality rate combined, with 905 reported in 2020 and 1323 in 2021, according to the Australian Bureau of Statistics.

While increased movement and relaxed rules following lockdowns caused transmission to increase, Deakin University chair in epidemiology Catherine Bennett blamed the arrival of Omicron and sub variants “first and foremost” for skyrocketing cases.

“It’s the most infectious variant we’ve had. It’s more equivalent to measles than the first strain and more than five times more infectious,” Professor Bennett said.

“It’s because we’ve got these sub variants. Every time the numbers start to drop a little bit, the next sub variant comes along with not even a brief respite between.”

Ms Bennett said while masks had been proven to reduce transmission, the debate over reintroducing mandates was too late.

“This is the long haul now. You have to move from rules to something else and that something else is really good public health communication and really good education … what I think we have missed is converting to a new way of managing this disease.”

Griffith University Infectious Diseases and Immunology director Nigel McMillan said targeted vaccines were the clear next step in combating the Omicron strain.

“What we’re really holding out for, of course, is that the next vaccine to come on to the market will be a multicomponent vaccine,” he said. “It’ll have the ancestral strain, plus Omicron, and that vaccine will be much, much better in terms of preventing infection, and even much, much better at preventing hospitalisation and serious illness.”

Professor McMillan said we should be making antivirals more accessible during earlier stages of infection. “Antivirals reduce the ability of the virus to grow inside you and therefore give your body a chance to recover better to limit the infection and for your immune system to kick in and really give you full recovery. “However, they have to be used early on in infection.”

Currently, antiviral drugs are limited to people who are moderately to severely immunocompromised or those aged over 65 with some sort of comorbidity, such as diabetes.

Professor McMillan has called on them to be made more widely available if supply allows.

*********************************************

3 Reasons America Is Great

1. A Culture of Self-Government

Americans, even before the birth of the United States in 1776, have always been a self-governing people. One of the first orders of business for the Pilgrim settlers when they arrived on the shores of Massachusetts was to create the Mayflower Compact, a basic statement of self-government and loyalty to the British crown.

The Jamestown colony in Virginia set up the House of Burgesses in 1619, the first legislative assembly in the New World.

Following their heritage, the British colonies in America almost immediately established institutions of self-government where community participation in the creation and upholding of laws was extensive.

But in the almost two centuries between the arrival of British colonists in America and the American Revolution, the colonists’ attachment to self-government deepened in comparison to their cousins back in England, where representation was often more symbolic rather than actual.

Amid Parliament’s ultimately foolish attempts to ham-handedly rein in the colonies at the end of the French and Indian War, it was the Crown that triggered the separation, the drive for total independence.

The thought of losing their grip on self-government made the colonists believe that they would soon end up in the vice of absolute tyranny. After years of discontent and pleading with British authorities to loosen their grip of control, the colonies rebelled.

The Declaration of Independence, a remarkable and timeless document, did not just lay out the essential God-given rights of life, liberty, and the pursuit of happiness in its most famous lines.

It also lays out the blow by blow steps of the British government and the colonies to establish that it was not just the rights of the colonists that had been violated, but that the very tools of self-government that could have rectified the situation had been arbitrarily stripped from them.

Americans were a people fitted for liberty and would tolerate no less.

2. The Constitution and the Rule of Law

When the Founding Fathers set about creating our own system of government, they codified the principles of self-government to serve countless generations unborn.

After the false start, so to speak, of the Articles of Confederation, the Framers wrote, and the American people ratified, the Constitution of the United States.

This remarkable document created a framework of America’s federal system that lasts still today despite the countless societal changes that have occurred in the last two centuries.

And while, in many ways, that constitutional and federal system has been eroded over time, Americans have remained committed to the idea of the Constitution as the glue that defines our government and binds Americans under a single system with many parts.

This is the cornerstone of liberty and order that defines our republic, ensures that we have an energetic but ultimately limited government.

Certainly, other nations have codified their laws and created founding documents of many stripes, but none matches the enduring legacy of the Constitution of the United States.

The American civilization may be young, but our system of government is quite old, and has excelled through the test of time.

3. The American Dream

Self-government and the Constitution have made America strong and adaptable to changing circumstances. Just as importantly, they’ve created a system whereby the average person can thrive and prosper.

The country’s strength lies in the millions of free-born, self-governing, and self-sufficient people who have taken the protections our unique government provides and created the most wealthy and prosperous nation in human history.

Americans are, and have always been, an enterprising people. But more than just create wealth, we have used our wealth and prosperity.

America’s attachment to the rule of law and defense of private property has allowed the growth of an expansive middle-class.

Yes, America has produced many titans of industry, but the real source of our strength is the fact that the average American has had opportunities to generate wealth and prosperity and create a vibrant civil society.

Many homesteaders went West to get rich, but many more went West to build families and ensure that their children would have a better life than they had.

That’s the spirit of America.

We have used our tremendous resources not only to improve our own lives but the lives of others.

And because of our enormous prosperity Americans remain, by far, the most generous people on Earth.

This Fourth of July, as with every Independence Day, we should be thankful and grateful to be Americans, we should be proud of what our country—though imperfect as all of mankind is imperfect—has accomplished.

It is important and essential that at this time we remember, defend, and pass on what has made this country great.

4 July, 2022

'Our country is going to hell in a hand-basket': WWII veteran celebrating 100th birthday breaks down in TEARS while discussing current state of America

It's hard to disagree with him. Who ever foresaw calls to defund the police and prosecutors who refuse to prosecute?

Remembering his time in the Marines, Carl Spurlin Dekel said that while fighting in the war was his biggest pride, soldiers had not died for the America of today

It comes amid plummeting approval ratings for those in the country's highest offices, including President Joe Biden

A World War II American veteran celebrating his 100th birthday broke down in tears as he discussed the current state of the country.

Reminiscing about his time in the Marines, Tampa Bay veteran Carl Spurlin Dekel said that while fighting in the war was his biggest pride, slain soldiers had not died for the America of today.

'People don't realize what they have,' Dekel told Fox13.

'The things we did and the things we fought for and the boys that died for it, it's all gone down the drain. Our country is going to hell in a hand-basket.'

Dekel became inconsolable as he spoke about the contrasts between the America he grew up in and the current state of affairs in the country.

His remarks came during an interview to commemorate Dekel's 100th birthday, which the Silver-medal holder spent with friends and family.

Dekel said he had lived a good life and hinted at his appreciation for the little things as the reason behind his longevity and good health.

'I really believe in this whole world and believe everything is beautiful. I mean if I wake up in the morning and see these plants, and all of those flowers, and the green grass in the ground, that's beautiful,' he told Fox13.

Dekel proudly showed his many medals from his time in the Marines. But the war veteran burst into tears when thinking about the friends he had lost to the war.

'We haven't got the country we had when I was raised, not at all,' he said.

'Nobody will have the fun I had. Nobody will have the opportunity I had. It's just not the same. And that's not what our boys, that's not what they died for.'

***************************************************

'Armed insurrection': What weapons did the Capitol rioters carry?

Recently, Scott MacFarlane, an NBC4 reporter in Washington who covers the Capitol riot prosecutions, tweeted, "As of tonight at least 65 of the Jan. 6 defendants have been charged with 'entering a restricted area with a dangerous or deadly weapon.' A counterpunch to those who argued this didn't appear like 'an armed insurrection.'"

It was just a tweet, which, by definition, can't contain much information, but it left open the question: What weapons did they have? What were the arms in the "armed insurrection"?

The Justice Department maintains a website listing the defendants and the federal charges against them in the sprawling Jan. 6 investigation. At this moment, about 670 people have been charged, many of them with misdemeanors such as "Parading, Demonstrating, or Picketing in a Capitol Building."

Of the cases involving weapons, there are four main charges: "Assaulting, Resisting, or Impeding Certain Officers Using a Dangerous Weapon"; "Entering and Remaining in a Restricted Building with a Deadly or Dangerous Weapon"; "Disorderly and Disruptive Conduct in a Restricted Building with a Deadly or Dangerous Weapon"; and "Engaging in Physical Violence in a Restricted Building with a Deadly or Dangerous Weapon."

Going through the Justice Department site, as well as some media databases, I counted 82 defendants who have been charged with at least one of those offenses. It's possible I missed a few, but I think they represent the vast majority of those who face weapons-related charges in the Capitol riot investigation. In each charge, prosecutors have specified the weapon the defendant is accused of using.

A few observations on the list. First, on the issue of guns. Five suspects — Christopher Michael Alberts, Lonnie Leroy Coffman, Mark Sami Ibrahim, Cleveland Grover Meredith Jr., and Guy Wesley Reffitt — are charged with possessing firearms. But none are charged with using them during the riot.

Alberts was arrested at 7:25 p.m., after the riot was over, when police enforcing the District of Columbia curfew suspected he had a handgun under his coat as he was leaving.

Coffman was arrested at about 6:30 p.m. after he told police that he was trying to get to his parked pickup truck. Officers found two handguns on Coffman's person and two more guns, along with possible bomb-making materials, in the truck.

Ibrahim was a Drug Enforcement Administration agent who had given his notice to resign and was on personal leave on Jan. 6; at the riot, he was carrying his DEA-issued badge and pistol.

Meredith was not in Washington at all for the riot. He arrived later that evening after allegedly texting a threatening message about House Speaker Nancy Pelosi. Meredith told police that "he had two firearms in his truck, and he knew that he was not supposed to have the firearms in Washington, DC. Therefore, he moved the firearms to his trailer," according to court documents. Officers found a handgun, a rifle, and hundreds of rounds of ammunition in the trailer.

Finally, court papers say Reffitt had a handgun on his person on Jan. 6.

So, those are the gun cases. Many observers have pointed out that other rioters surely had guns. Since so few were arrested and searched at the scene, that is impossible to know. But it's certainly possible. What is more certain is that none of the suspects fired any guns at any point during the riot. The only shot that was fired during that time was by Capitol Police Lt. Michael Byrd, who shot and killed rioter Ashli Babbitt as she tried to force her way into an area near the House chamber.

As for the rest of the weapons, six defendants are charged with having a knife, although none are accused of using the weapon on another person. Five defendants are accused of having a Taser or stun gun. Three are charged with having an ax. Four are charged with having a baseball bat. Seven are charged with having a crutch. Eleven are charged with having a baton of some sort. Thirteen are accused of having some sort of pepper or other irritant spray. Nineteen are charged with having a pole, usually a pole for the flags they carried. Eight are accused of having a shield, several of them police shields they apparently took at the scene.

Some of the weapons were obviously brought with the intention of being in a fight. Others were clearly improvised on the spur of the moment; in one case, the deadly or dangerous weapon used was a desk drawer. In another, it was a traffic barrier. In yet another, it was a helmet. That doesn't mean those objects could not be dangerous; one could beat a person to death with a desk drawer. But it does suggest the rioter did not arrive at the Capitol bent on armed insurrection.

In addition, the overall numbers are relatively small. Eighty-two people charged with weapons-related offenses, out of how many? That is about 12% of the 670 or so currently charged. And 670 is smaller than the total number of rioters on the Capitol grounds on Jan. 6. Does that amount to an "armed insurrection"? Especially when just five people have been charged with possessing firearms, the weapon of choice for modern armed insurrectionists, and one of them didn't arrive until after it was all over, and none of them fired the weapons, even in the intensity of the physical struggle that day?

And that is the problem with the "armed insurrection" talking point. By any current American standard of civil disorder, what happened on Jan. 6 was a riot. There were some instigators, and there were many more followers. A small number were anticipating a fight, probably with antifa. And as the day went on, some people lost their heads and did things they should regret for a very long time. But a look at the Justice Department prosecutions simply does not make the case that it was an "armed insurrection."

************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

**************************************************

Monday, July 04, 2022


'Our country is going to hell in a hand-basket': WWII veteran celebrating 100th birthday breaks down in TEARS while discussing current state of America

It's hard to disagree with him. Who ever foresaw calls to defund the police and prosecutors who refuse to prosecute?

Remembering his time in the Marines, Carl Spurlin Dekel said that while fighting in the war was his biggest pride, soldiers had not died for the America of today

It comes amid plummeting approval ratings for those in the country's highest offices, including President Joe Biden

A World War II American veteran celebrating his 100th birthday broke down in tears as he discussed the current state of the country.

Reminiscing about his time in the Marines, Tampa Bay veteran Carl Spurlin Dekel said that while fighting in the war was his biggest pride, slain soldiers had not died for the America of today.

'People don't realize what they have,' Dekel told Fox13.

'The things we did and the things we fought for and the boys that died for it, it's all gone down the drain. Our country is going to hell in a hand-basket.'

Dekel became inconsolable as he spoke about the contrasts between the America he grew up in and the current state of affairs in the country.

His remarks came during an interview to commemorate Dekel's 100th birthday, which the Silver-medal holder spent with friends and family.

Dekel said he had lived a good life and hinted at his appreciation for the little things as the reason behind his longevity and good health.

'I really believe in this whole world and believe everything is beautiful. I mean if I wake up in the morning and see these plants, and all of those flowers, and the green grass in the ground, that's beautiful,' he told Fox13.

Dekel proudly showed his many medals from his time in the Marines. But the war veteran burst into tears when thinking about the friends he had lost to the war.

'We haven't got the country we had when I was raised, not at all,' he said.

'Nobody will have the fun I had. Nobody will have the opportunity I had. It's just not the same. And that's not what our boys, that's not what they died for.'

***************************************************

'Armed insurrection': What weapons did the Capitol rioters carry?

Recently, Scott MacFarlane, an NBC4 reporter in Washington who covers the Capitol riot prosecutions, tweeted, "As of tonight at least 65 of the Jan. 6 defendants have been charged with 'entering a restricted area with a dangerous or deadly weapon.' A counterpunch to those who argued this didn't appear like 'an armed insurrection.'"

It was just a tweet, which, by definition, can't contain much information, but it left open the question: What weapons did they have? What were the arms in the "armed insurrection"?

The Justice Department maintains a website listing the defendants and the federal charges against them in the sprawling Jan. 6 investigation. At this moment, about 670 people have been charged, many of them with misdemeanors such as "Parading, Demonstrating, or Picketing in a Capitol Building."

Of the cases involving weapons, there are four main charges: "Assaulting, Resisting, or Impeding Certain Officers Using a Dangerous Weapon"; "Entering and Remaining in a Restricted Building with a Deadly or Dangerous Weapon"; "Disorderly and Disruptive Conduct in a Restricted Building with a Deadly or Dangerous Weapon"; and "Engaging in Physical Violence in a Restricted Building with a Deadly or Dangerous Weapon."

Going through the Justice Department site, as well as some media databases, I counted 82 defendants who have been charged with at least one of those offenses. It's possible I missed a few, but I think they represent the vast majority of those who face weapons-related charges in the Capitol riot investigation. In each charge, prosecutors have specified the weapon the defendant is accused of using.

A few observations on the list. First, on the issue of guns. Five suspects — Christopher Michael Alberts, Lonnie Leroy Coffman, Mark Sami Ibrahim, Cleveland Grover Meredith Jr., and Guy Wesley Reffitt — are charged with possessing firearms. But none are charged with using them during the riot.

Alberts was arrested at 7:25 p.m., after the riot was over, when police enforcing the District of Columbia curfew suspected he had a handgun under his coat as he was leaving.

Coffman was arrested at about 6:30 p.m. after he told police that he was trying to get to his parked pickup truck. Officers found two handguns on Coffman's person and two more guns, along with possible bomb-making materials, in the truck.

Ibrahim was a Drug Enforcement Administration agent who had given his notice to resign and was on personal leave on Jan. 6; at the riot, he was carrying his DEA-issued badge and pistol.

Meredith was not in Washington at all for the riot. He arrived later that evening after allegedly texting a threatening message about House Speaker Nancy Pelosi. Meredith told police that "he had two firearms in his truck, and he knew that he was not supposed to have the firearms in Washington, DC. Therefore, he moved the firearms to his trailer," according to court documents. Officers found a handgun, a rifle, and hundreds of rounds of ammunition in the trailer.

Finally, court papers say Reffitt had a handgun on his person on Jan. 6.

So, those are the gun cases. Many observers have pointed out that other rioters surely had guns. Since so few were arrested and searched at the scene, that is impossible to know. But it's certainly possible. What is more certain is that none of the suspects fired any guns at any point during the riot. The only shot that was fired during that time was by Capitol Police Lt. Michael Byrd, who shot and killed rioter Ashli Babbitt as she tried to force her way into an area near the House chamber.

As for the rest of the weapons, six defendants are charged with having a knife, although none are accused of using the weapon on another person. Five defendants are accused of having a Taser or stun gun. Three are charged with having an ax. Four are charged with having a baseball bat. Seven are charged with having a crutch. Eleven are charged with having a baton of some sort. Thirteen are accused of having some sort of pepper or other irritant spray. Nineteen are charged with having a pole, usually a pole for the flags they carried. Eight are accused of having a shield, several of them police shields they apparently took at the scene.

Some of the weapons were obviously brought with the intention of being in a fight. Others were clearly improvised on the spur of the moment; in one case, the deadly or dangerous weapon used was a desk drawer. In another, it was a traffic barrier. In yet another, it was a helmet. That doesn't mean those objects could not be dangerous; one could beat a person to death with a desk drawer. But it does suggest the rioter did not arrive at the Capitol bent on armed insurrection.

In addition, the overall numbers are relatively small. Eighty-two people charged with weapons-related offenses, out of how many? That is about 12% of the 670 or so currently charged. And 670 is smaller than the total number of rioters on the Capitol grounds on Jan. 6. Does that amount to an "armed insurrection"? Especially when just five people have been charged with possessing firearms, the weapon of choice for modern armed insurrectionists, and one of them didn't arrive until after it was all over, and none of them fired the weapons, even in the intensity of the physical struggle that day?

And that is the problem with the "armed insurrection" talking point. By any current American standard of civil disorder, what happened on Jan. 6 was a riot. There were some instigators, and there were many more followers. A small number were anticipating a fight, probably with antifa. And as the day went on, some people lost their heads and did things they should regret for a very long time. But a look at the Justice Department prosecutions simply does not make the case that it was an "armed insurrection."

************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

**************************************************

Sunday, July 03, 2022


Top FDA advisor warns that new Covid-19 booster formulated for Omicron variant are 'no better' than existing shots

A key advisor to the Food and Drug Administration (FDA) is warning that plans for the U.S. government to roll out Covid-19 boosters tailored to the Omicron variant could be in vain, as the shots provide little that existing shots don't already.

Dr. Paul Offit, director of the Vaccine Education Center at the Children's Hospital of Philadelphia and member of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC), wrote in a STAT News op-ed that he would like to see more data in favor of the shots before the government made a heavy investment into them.

Offit was one of two VRBPAC members who voted against the shots, which were recommended by the agency's top advisory panel on vaccines by a 19-2 vote on Tuesday.

The FDA is aiming to get reformulated Covid-19 shots that specifically target the Omicron variant out to Americans as early as October. Currently available shots were formulated to target the virtually extinct original Wuhan strain of the virus. Antibodies provided by the original shots still are effective at preventing severe infection or death from Omicron, which is also a generally more mild variant compared to its predecessors.

It comes as Covid cases in America remain steady, with the nation recorded 110,688 cases per day and 376 deaths per day.

The Omicron variant emerged in late 2021 and took the world by storm: It was the most mutated version of the virus yet, and its ability to circumvent vaccine immunity caught the largely vaccinated population of many developed countries off-guard.

It rapidly spread, causing case figures in the U.S. to reach 800,000 daily.

This sparked demand for Covid-19 boosters that could specifically target the mutant strain and prevent infection.

Both Pfizer and Moderna have updated their jabs since and are expected to soon receive authorization from the FDA to roll out the shots either this week or next.

Offit notes that in data submitted by both companies, the additional Omicron booster raised the antibody levels twofold, though he doubts they'll provide much effectiveness overall.

'That kind of twofold difference is, for example, similar to the modestly greater peak in neutralizing antibodies triggered by the first two doses of the Moderna vaccine compared with the Pfizer vaccine,' he explained, noting that the protections provided were similar.

'Those two vaccines provided almost identical protection against mild and severe Covid-19, although the benefits of the Pfizer vaccine waned a bit quicker over time.'

Data submitted by the companies focused on antibody levels found in blood samples pulled from trial participants.

Antibodies provide diminishing returns, though, and doubling antibody levels does not exactly provide double the protection.

Offit says data on actual protection from infection, hospitalization and death needs to be collected first to determine how valuable these newly formulated shots are.

'Moderna and Pfizer executives have claimed that the Omicron vaccines will be protective for longer. That may be true, but how long is longer? A few weeks? A month or two?' he asks.

The FDA is eager to get these shots out, already setting targets for rollout before they've even been authorized.

Dr. Peter Marks, director of the Center for Biologics Evaluation and Research, the agency's top regulatory body for vaccines, said Tuesday the aim was to make Omicron-specific jabs available by September.

Demand for the shots may have plummeted in recent months even as Americans' worry about the pandemic seems to decline.

A May Gallup poll found that only 31 percent of Americans report being either 'somewhat worried' or 'very worried' about catching Covid.

The poll signals the shifting state of the virus as America approaches the summer months. In previous years, the warm weather months have come with large, devastating virus surges.

The survey was conducted in mid-April, when the trend of declining cases that had existed for nearly three months to that point began to reverse.

Participants were asked of their feelings about the pandemic, the virus and what sort of personal mitigations strategies they were using - or ignoring - in their day-to-day life.

The study also found that 64 percent of Americans believed the pandemic was 'getting better.' At the time of the survey, cases had just dropped below 30,000 per day, making it one of the lowest points since the start of the pandemic in March 2020.

Around 21 percent of Americans said they believed the situation was about the same, and only 12 percent believed it was getting worse. The last time this few Americans believed the situation was worsening was summer 2021, when cases were at a low point, just before the explosion of the Delta variant.

These optimistic feelings have led to some changes in behavior as well. Only 17 percent of Americans reported they were still social distancing, the lowest percentage so far. Just under a third of Americans said they have avoided large crowds, a fifth reported avoiding public places and just 15 percent avoided small gatherings.

Those figures are also all pandemic-lows, Gallup reports.

Despite shifts in social distancing, Americans seem to be clinging on to masks. The poll found that half of Americans still wear a face mask in public places. While the 50 percent figure is also a pandemic low, it's significantly higher than the number of people reporting they're still worried about the virus.

*****************************************************

America’s abortion debate isn’t coming to Britain

Probably because Britain is much less religious

Once again, Westminster politics has mistaken Britain for America. The Conservative party may be in hoc to a blonde tousle-haired populist, but it isn’t quietly stacking the judiciary with pro-life justices in order to ban abortion. This is partly because the British constitution doesn’t work that way, but mostly because there’s no popular demand to do so.

For all that it may be convenient to pretend otherwise, abortion is simply not a salient political issue in Britain. Keir Starmer described the Supreme Court’s decision as ‘a massive setback for women’s rights’. Boris Johnson called it a ‘big step backwards’, stating that he has ‘always believed in a woman’s right to choose’. For the Liberal Democrats, Layla Moran noted that ‘here we are not under threat, thank God’.

There is a remarkable degree of consensus between parties on what the law should be, and this reflects the views of the public. Some 85 per cent of the population believe women should have the right to an abortion. Just 5 per cent do not. Over 53 per cent of the population want to keep the time limits as they are or increase them, compared to 28 per cent in favour of reductions or bans. It’s reasonable to feel sympathy for those affected by American politics. It isn’t reasonable to pretend what happens there could happen here.

Obviously, this hasn’t stopped people trying. From hyperventilating articles on the threat posed to women’s rights in Britain to politicians tabling urgent questions in parliament on the government’s response to American domestic matters, the usual confusion of British and American politics has been in full swing.

Labour MP Stella Creasy tweeted that Britons should ‘be prepared’. After all, ‘no one thought American Supreme Court would ever overturn a right previously granted either’. Her message to Americans? ‘Your fight is our fight. They won’t stop trying to control women’. Another MP, Diana Johnson, claimed that ‘right-wing American groups and media will now feel fully emboldened to campaign for the rolling back of women’s rights in the United Kingdom’.

Quite how this is meant to happen isn’t clear. Every such article and argument eventually concedes two points: there’s no mass movement arguing for the change, and there’s no party advocating for it. To this, we can add one more: where there is pressure for abortion law to change, it has generally been in a progressive direction.

Britain’s Conservative party has been in power for 12 years. In this time, parliament has consistently moved to make abortion easier. In 2017, a scheme was introduced to fund abortions in England – and travel costs – for Northern Irish women. In 2018, legislation was passed to allow women to take the second abortion pill at home. In 2019, Westminster altered Northern Irish law – going above devolution – to decriminalise abortion and allow access. In 2020, taking both abortion pills at home was temporarily legalised. And in 2022, this was made permanent, while the government passed regulations to ensure that abortion services were provided in Northern Ireland.

This shouldn’t be surprising. Once again, with feeling: Britain is not America, no matter how much we seem to think it is. When people ask what the Roe decision means for Britain, it’s no different to asking what the decision to protect concealed carry rights means for policing in London. It’s an irrelevance to day-to-day British life, no matter how much social media may give the impression that our own rights hang in the balance.

************************************************

Also see my other blogs. Main ones below:

http://edwatch.blogspot.com (EDUCATION WATCH)

http://antigreen.blogspot.com (GREENIE WATCH)

http://pcwatch.blogspot.com (POLITICAL CORRECTNESS WATCH)

http://australian-politics.blogspot.com/ (AUSTRALIAN POLITICS)

http://snorphty.blogspot.com/ (TONGUE-TIED)

https://immigwatch.blogspot.com/ (IMMIGRATION WATCH)

https://awesternheart.blogspot.com/ (THE PSYCHOLOGIST)

**************************************************